We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.2B
AUM Growth
-$2.13B
Cap. Flow
+$212M
Cap. Flow %
1.6%
Top 10 Hldgs %
51.27%
Holding
122
New
17
Increased
44
Reduced
28
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$853M
2
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$778M
3
AABA
Altaba Inc
AABA
+$385M
4
PPLI
People Inc
PPLI
+$348M
5
BABA icon
Alibaba
BABA
+$288M

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$964M
2
APC
Anadarko Petroleum
APC
+$738M
3
ARRY
Array Biopharma Inc
ARRY
+$394M
4
BKNG icon
Booking.com
BKNG
+$128M
5
EFX icon
Equifax
EFX
+$117M

Sector Composition

Rank Sector Weight
1 Healthcare 39.58%
2 Technology 13.07%
3 Communication Services 10.54%
4 Industrials 6.1%
5 Consumer Discretionary 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPL
26
DELISTED
Buckeye Partners, L.P.
BPL
$160M 1.21%
3,900,000
+3,180,143
+442% +$131M
ASND icon
27
Ascendis Pharma A/S
ASND
$16.1B
$149M 1.13%
1,550,000
+10,000
+0.6% +$1.12M
PANW icon
28
Palo Alto Networks
PANW
$296B
$124M 0.94%
+3,660,000
New +$130M
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$30.4B
$121M 0.91%
1,500,000
+400,000
+36% +$31.6M
IOVA icon
30
Iovance Biotherapeutics
IOVA
$1.99B
$110M 0.83%
6,025,000
+300,000
+5% +$6.63M
AZN icon
31
AstraZeneca
AZN
$252B
$106M 0.8%
1,187,893
-862,107
-42% -$74.8M
MYOK
32
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$106M 0.8%
2,030,397
+30,397
+2% +$1.62M
SE icon
33
Sea Limited
SE
$69.3B
$104M 0.79%
3,375,000
– –
TRU icon
34
TransUnion
TRU
$15.2B
$102M 0.77%
1,255,138
-417,205
-25% -$33.5M
XLRN
35
DELISTED
Acceleron Pharma
XLRN
$94.8M 0.72%
2,400,000
+25,000
+1% +$1.08M
EFX icon
36
Equifax
EFX
$20.5B
$89.3M 0.67%
635,056
-828,723
-57% -$117M
GWR
37
DELISTED
Genesee & Wyoming Inc.
GWR
$86.5M 0.65%
782,673
+7,673
+1% +$845K
ALDR
38
DELISTED
Alder Biopharmaceuticals
ALDR
$78.6M 0.59%
+4,165,000
New +$47.6M
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$78.2M 0.59%
1,612,069
+487,069
+43% +$25.4M
BRMK
40
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$77.3M 0.58%
+75,000,000
New +$778M
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$391M
$76.6M 0.58%
1,274,212
+314,212
+33% +$23.3M
ABBV icon
42
AbbVie
ABBV
$435B
$75.7M 0.57%
+1,000,000
New +$68.6M
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
$70.1M 0.53%
1,750,000
-250,000
-13% -$11.5M
GRFS
44
Grifois
GRFS
$5.4B
$62.4M 0.47%
3,113,222
+33,139
+1% +$711K
BKNG icon
45
Booking.com
BKNG
$160B
$61.1M 0.46%
778,475
-1,657,750
-68% -$128M
CY
46
DELISTED
Cypress Semiconductor
CY
$57.5M 0.43%
+2,464,966
New +$56.4M
CVS icon
47
CVS Health
CVS
$125B
$56.8M 0.43%
900,000
+77,500
+9% +$4.59M
RDUS
48
DELISTED
Radius Health, Inc.
RDUS
$52.9M 0.4%
2,054,486
+11,337
+0.6% +$278K
SAGE
49
DELISTED
Sage Therapeutics
SAGE
$52.3M 0.4%
372,800
-127,200
-25% -$21.3M
ZYME icon
50
Zymeworks
ZYME
$1.74B
$42.9M 0.32%
1,731,500
-24,970
-1% -$626K
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Farallon Capital Management held 122 positions worth $13.2B, down 14% from $15.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management's Q3 2019 filing shows 17 new, 44 increased, 28 reduced and 23 closed positions. Its largest new stake was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M. The largest sale was Red Hat Inc, an estimated $964M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

  • Farallon Capital Management's largest Q3 2019 buy was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M.
  • Farallon Capital Management added most to Allergan plc in Q3 2019, an estimated $853M increase.
  • Farallon Capital Management's biggest Q3 2019 reduction was Booking.com, cutting an estimated $128M.
  • Farallon Capital Management fully exited Red Hat Inc in Q3 2019, selling an estimated $964M.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.2B portfolio in Q3 2019.
  • Farallon Capital Management opened 17 new positions and closed 23 in Q3 2019.
  • Farallon Capital Management's portfolio value fell 14% quarter-over-quarter to $13.2B.

Based on Farallon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.